Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

90-day Postoperative Morbidity and Mortality After Elective Surgery for Esophageal and Esophagogastric Junction Cancer

NCT06277921 is registered in ClinicalTrials.gov with P. Herzen Moscow Oncology Research Institute as lead sponsor.

NCT NCT06277921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
90-day Postoperative Morbidity and Mortality After Elective Surgery for Esophageal and Esophagogastric Junction Cancer
Lead sponsor
P. Herzen Moscow Oncology Research Institute
Phase
Observational
Overall status
Completed
Start date
March 18, 2024
Completion date
January 20, 2025
Enrollment
230 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, oesophageal cancer, siewert type i adenocarcinoma of esophagogastric junction, siewert type iii adenocarcinoma of esophagogastric junction